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Short-term treatment of cultured HGT-1 cells with histamine produced a time-dependent (half-life: 20 min) 
and homologous desensitization of histamine H, receptor activity mediating CAMP generation in HGT-1 
cells and gastric acid secretion in normal gastric mucosa. Histamine treatment resulted in loss of response 
of the adenylate cyclase to histamine in purified plasma membranes, but had no effect on basal, vasoactive 
intestinal peptide (VIP)- or NaF-stimulated enzyme activities. We propose that the desensitization of gastric 
histamine H, receptor by histamine evidenced in cellular or subcellular preparations from HGT-1 cells could 
be involved in the physiological regulation and pharmacological control of gastric cell function in man. 
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1. INTRODUCTION 
Desensitization (the loss of drug or hormone 
response after exposure of cells to those agents) 
has been documented for a variety of ligands in- 
cluding glucagon, insulin, TSH, LH, FSH, pro- 
staglandins, opiates, catecholamines, gastrin and 
carbachol. No data are yet available for such a 
mechanism after histamine interaction on tissues 
bearing HZ receptors. The human gastric cancer 
cell line HGT-1 [l], which possesses peptide hor- 
mone and histamine Hz receptors similar to those 
evidenced in gastric glands isolated from man or 
laboratory animals [2-81, is therefore a suitable 
model for this study. 
modification of the histamine-sensitive adenylate 
cyclase in purified plasma membranes. This work 
has been presented in abstract form [9]. 
2. MATERIALS AND METHODS 
2.1. Chemicals 
We describe here results from experiments which 
indicate that the agonist-induced esensitization of 
the gastric histamine HZ receptor mediating CAMP 
generation in HGT-1 cells (and acid secretion in 
normal gastric epithelia) is related to homologous 
Highly purified natural porcine vasoactive in- 
testinal peptide (VIP) was purchased from Pro- 
fessor V. Mutt (GIH Laboratory, Stockholm). 
Cyclic AMP, NaF, 3-isobutyl-1-methylxanthine 
(IBMX), dithiothreitol, phenylmethylsulfonyl 
fluoride (PMSF), histamine dihydrochloride, GTP 
and pure ATP were from Sigma (St. Louis, MO). 
Creatine phosphate (A grade) and phosphocreatine 
kinase were from Calbiochem and Boehringer, 
respectively. Na12? was from the Radiochemical 
Centre (Amersham). 
2.2. HGT-1 cell line 
* To whom correspondence and reprint requests should 
be addressed 
The HGT-1 cells, generously provided by Dr C. 
Laboisse (INSERM U.239, FacultC de MCdecine 
Xavier Bichat, Paris) were routinely cultured in 
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Dulbecco’s modified Eagle medium (DMEM), as 
in [ 11. HGT-1 cells between passages 89 and 95 
were washed (3 times in DMEM) and incubated at 
37°C for 20, 60 or 180 min in culture flasks with 
low3 M histamine. Control and histamine-treated 
HGT-1 cells were washed (3 times at 37°C) with 
phosphate-buffered saline (calcium-free) and 
removed from culture flasks after addition of 
0.02% EDTA (37°C 1 min). Isolated HGT-1 cells 
were then washed (3 times at 20°C) and centri- 
fuged at 200 x g for 3 min in 40 ml Krebs-Ringer 
phosphate buffer (KRP, pH 7.4). Cell viability was 
about 90-95% in control or histamine-treated 
HGT-1 cells, before and after the incubations for 
CAMP determinations described below. 
2.3. Cellular CAMP generation 
In a standard assay, 150 ~1 from the HGT-1 cell 
suspension (l-2 x lo6 cells/ml) were preincubated 
at 20°C for 10 min in 250 pl KRP buffer contain- 
ing 1% bovine serum albumin (BSA) and 2 mM 
IBMX. The reaction was initiated by addition of 
histamine at various concentrations (100 ~1) and 
stopped after 15 min incubation by adding 50 ~1 of 
11 N HC104. Cyclic AMP was determined by the 
radioimmunoassay method [5]. Absolute values 
are expressed as pmol CAMP produced per lo6 
HGT- 1 cells. 
2.4. Membrane-bound adenylate cyclase 
preparation and assay 
Control or histamine-treated HGT-1 cells were 
resuspended (20 x lo6 cells per ml) in 10 mM 
Tris-HCl buffer (pH 7.5) containing 1 mM 
EDTA, 30 mM NaCl, 1 mM dithiothreitol, 5 FM 
PMSF, and disrupted with a Polytron 
homogenizer (Kinematica, Luzern, Switzerland) 
using 3 bursts of 5 s. The homogenate was layered 
over 10 ml of a 41% solution of sucrose in the 
homogenization buffer and centrifuged (95000 x 
g, 1 h, 4°C) in a Beckman SW27 swinging bucket 
rotor [lo]. The white interfacial band of mem- 
branes was collected and diluted 4 times in 
homogenization buffer. The membranes were col- 
lected by centrifugation at 4°C (40000 X g, 
30 min) in a Sorvall centrifuge RC-5B (Newton, 
CT). The membranes were then stored frozen at 
- 80°C for 1 week. Adenylate cyclase activity was 
measured by a modification of the method in Ill]. 
The standard incubation mixture (final volume, 
228 
250~1) contained 1 mM ATP, 5 mM MgClz, an 
ATP-regenerating system (20 mM creatine 
phosphate, 1 mg/ml phosphocreatine kinase), 
0.2 mM IBMX, 1 mg/ml BSA, 1 mM EGTA, 
200pg/ml bacitracin, 2OOpM GTP and test 
substances in 25 mM Tris-HCl (pH 7.5). Reaction 
was initiated by addition of the enzyme (10 pg 
membrane protein per tube) and the mixture was 
incubated at 30°C for the indicated times. Data are 
expressed as nmol CAMP produced per pg mem- 
brane protein. 
3. RESULTS 
Fig.1 shows that short-term treatment of 
cultured HGT-1 cells with histamine produced a 
progressive decline in the subsequent efficacy of 
histamine on H2 receptor activity. After a 3 h 
preincubation with the hormone (10e3 M), there 
was a remarkable reduction of the CAMP response 
to a second challenge with histamine 
(10-7-10-3 M). After only 20 min, the response 
was reduced to 50% of the control response. Basal 
levels of CAMP were not affected by exposure of 
cultured HGT-1 cells with histamine. As illustrated 
in fig.2, the histamine-induced ecreases in hor- 
monal responses observed in the experiment shown 
in fig. 1 were associated with the desensitization of 
adenylate cyclase to histamine. NaF (lo-17-fold) 
and histamine (4-6-fold) increased adenylate 
cyclase activity in purified plasma membranes 
(fig.2,left) as in crude plasma membranes prepared 
from HGT-1 cells [3]. Reaction rates were linear 
~Histamme ] ,-log M 
Fig.1. Time course of desensitization of histamine Hz 
receptor activity in cultured HGT-1 ceils. HGT-1 cells 
were preincubated at 37°C with 10m3 M histamine in 
culture flasks for the indicated time, then washed, 
isolated and incubated for 15 min in the absence (basal 
CAMP production) or presence of different histamine 
concentrations before the assay of CAMP. Data are 
means + SE from 3 separate experiments performed in 
duplicate or triplicate. 
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Fig.2. Effect of culturing HGT-1 cells with histamine on 
the kinetics of histamine- and NaF-stimulated adenylate 
cyclase activity in purified plasma membranes. Control 
or histamine-treated HGT-1 cells (10e3 M histamine, 3 h 
at 37°C in culture flasks, as in fig. 1) were compared for 
their adenylate cyclase activities in the absence (basal 
activity, 0) or presence of NaF (lo-’ M, A) or 
histamine (10m3 M, l ). We have verified that adenylate 
cyclase activities under basal or stimulated conditions 
were linear with protein concentrations (3-15 pg 
membrane protein/tube). Purified plasma membranes 
(about 10 pg membrane protein/tube) were incubated at 
30°C for the indicated time. Data are means f SE from 
4 (control HGT-1 cells) to 6 experiments (histamine- 
treated cells) performed in duplicate or triplicate. 
with time (O-20 min) in the absence or presence of 
10e3 M histamine or lop2 M NaF. In HGT-1 cells 
cultured for 3 h at 37’C in the presence of lop3 M 
histamine, adenylate cyclase was insensitive to 
histamine during the period considered 
(fig.2,right). In contrast, the ubiquitous activator 
of the enzyme (NaF) was still able to produce a 
comparable increase in adenylate cyclase activity, 
measured in control HGT-1 cells. Similarly, the 
VIP-induced adenylate cyclase activation remained 
unchanged after histamine treatment (not shown). 
4. DISCUSSION 
Our experiments conducted on the human 
gastric cancer cell line HGT-1 are the first example 
of the homologous desensitization of the gastric 
histamine HZ receptor. 
Decreased histamine HZ receptor response in 
human granulocytes [121 has been reported in vivo, 
in asthmatic patients [ 131, and desensitization by 
histamine of the histamine Hi receptor-mediated 
glycogen hydrolysis has been characterized in 
vitro, in rat brain slices [14]. 
Pretreatment of HGT-1 cells with histamine pro- 
duced a rapid (half-life, 20 min) and remarkable 
suppression of H2 receptor activity (cellular CAMP 
generation and adenylate cyclase activation) in 
cultured HGT-1 cells. This desensitization process 
is observed in intact HGT-1 cells after serial 
washings or after membrane-bound adenylate 
cyclase preparation. It is of interest o note that the 
membrane desensitization does not seem to alter 
the regulatory feature of the adenylyl cyclase 
system, i.e., the fluoride stimulation of the en- 
zyme, known to exert a direct effect on the N com- 
ponent. Similarly, we demonstrated that short- 
term or chronic treatment of HGT-1 cells with 
histamine [15] or with the Hz receptor antagonist 
SKF 93479 [15,16] resulted in the homologous 
disappearance of histamine Hz receptor activity, 
since receptor activation by peptide hormones 
(VIP, pancreatic glucagon, gastric inhibitory pep- 
tide) remained unchanged in the system. However, 
in this case, the loss of the CAMP response to 
histamine in HGT-1 cells was due to a slow onset 
of dissociation of SKF 93479 from the Hz recep- 
tor, and was not observed after the classic Hz an- 
tihistamine cimetidine [ 1% 171. 
Desensitization may be produced by a number 
of different mechanisms, including uncoupling of 
the receptor to the adenylate cyclase or biological 
responses, a decrease in the concentration of recep- 
tors (internalization, receptor degradation), or 
progressive alteration of adenylate cyclase or 
phosphodiesterase activity. Further characteriza- 
tion of the desensitization of the gastric Hz recep- 
tor in normal and cancerous gastric cells will be 
presented elsewhere (in preparation). 
Occupancy of the Hz receptor by histamine 
results in a cascade of biochemical events, in- 
cluding adenylate cyclase and CAMP-dependent 
protein kinase activation [ 181, leading to gastric 
acid secretion (review [19]). In the stomach, 
histamine-containing cells occur in the lamina pro- 
pria, in close proximity to the acid-secreting 
parietal cells [20]. It is therefore conceivable that 
histamine HS receptors are exposed to histamine 
released by histaminocytes in vivo or in vitro dur- 
ing gastric cell preparation or separation, produc- 
ing alteration (desensitization) in Hz receptor ac- 
tivity. The homologous desensitization of Hz 
229 
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receptor-mediated adenylyl cyclase activity by 
histamine presented here could therefore be in- 
volved in the physiological regulation and phar- 
macological control of gastric cell function in man. 
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